SEC Form 4 · accession 0001144204-16-118492
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Hui Li
Director
Period of report
Aug 11, 2016
Accepted (ET)
Aug 12, 2016 · 8:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2016 | A | 269 | $0.00 | D | 269 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were received by the Reporting Person as part of a pro-rata distribution, without any additional consideration, by WP X Biologics LLC, a Delaware limited liability company.